Amgen to Present at Morgan Stanley Global Healthcare Conference
Amgen is set to present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026. The company's executive vice president of Research and Development, Jay Bradner, and chief financial officer, Thomas Dittrich, will be presenting.
The webcast will be broadcast simultaneously over the internet and will be available to news media, investors, and the general public on Amgen's website. It can also be found in the Investors section of the company's website under Investor Relations Events Calendar.
Amgen is a biotechnology industry leader that has been consistently recognized for its innovation and workplace culture. The company discovers, develops, manufactures, and delivers innovative medicines to fight some of the world's toughest diseases.